SUN bioscience

Switzerland
Malters, Lucerne, Switzerland

Company profile

SUN bioscience company profile

SUN bioscience is enabling personalized medicine through patient-specific organoids cultured on SUN’s proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early on in drug development. The SUN technology is solving the problems that organoid culture today cannot be scaled and automated. This will introduce a new area of drug discovery where we can understand drug performance outside of an animal or a human being.

Business identity

Contact email
[email protected]
Phone number
+41216931615
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2015-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
5
Last funding
Debt Financing / $553,124 / 2021-05-11
Last equity funding
Seed
Investors
5
Lead investors
2
Founders
2
Articles
12

Founders and investors

Founders

Nathalie BrandenbergSylke Hoehnel

Lead investors

Foundation for Innovation and Technology (FIT)FOUNDER.org

Investors

Acequia Capital (AceCap)Foundation for Innovation and Technology (FIT)FOUNDER.orgMassChallengePossible Ventures